UnitedHealth Group provided a full-year profit forecast on Tuesday after suspending its prior outlook in May, revealing ...

U.S. stocks closed lower on Tuesday as the S&P 500 and Nasdaq retreated from record highs after some disappointing corporate ...

Humana (NYSE:HUM) traded ~7% higher in the premarket on Wednesday after the managed care firm, with its Q2 2025 results, ...

Shares in Asia are mixed after the U.S. and China ended their latest round of trade talks without a deal. U.S, futures edged ...

Second-quarter adjusted earnings came in at $6.27 a share on sales of $32.4 billion. beating analysts' expectations.

Tack on a half-dozen zeros to your CVS receipt and you'll get a sense of the sticker shock afflicting state officials, insurers and hospitals dealing with the soaring cost of prescription drugs in ...

U.S. stocks end lower, with the S&P 500 and Nasdaq pausing its run to records as the Fed meets on rates and ahead of Mag 7 earnings.

UnitedHealth’s (NYSE: UNH) turbulent run in 2025 is escalating after the firm reported disappointing Q2 earnings results.